• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-60-150-120-P6
Device Problems Stretched (1601); Difficult or Delayed Activation (2577); Physical Resistance/Sticking (4012)
Patient Problem Embolism (1829)
Event Date 09/11/2020
Event Type  Injury  
Manufacturer Narrative
The device was received.The investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that on (b)(6) 2020, the patient presented with a tight iliac bifurcation and a heavily calcified superficial femoral artery (sfa) lesion.The operator had difficulty accessing the sfa with the guide catheter and unspecified wire due to anatomy.Vessel preparation was performed using a 5.0 plain balloon for 2 minutes and a 6.0 drug eluting balloon for another 2 minutes.Reportedly, the vessel remained heavily calcified following vessel preparation and inadequate vessel preparation was possible.One supera stent delivery system (sds) advanced and stent was successfully implanted, without any unusual resistance or issue.A second supera sds advanced without issue to the treatment sfa site.During stent deployment, resistance was felt with the thumbslide, making it difficult to advance and retract.The operator was able to deploy the stent using the thumbslide although there was this resistance.This stent had slightly elongated due to the difficult deployment, however, it remained implanted at the intended location.The heavily calcified anatomy was thought to be the reason for the difficult deployment.Following, a third supera sds advanced without issue and stent deployed successfully.At the end of the procedure, an embolus was observed in the lower extremities.Tpa was provided as treatment and surgery was considered although not performed.There was no additional adverse patient sequela and the procedure was completed without further issues reported.There was no clinically significant delay.No additional information was provided regarding this issue.
 
Manufacturer Narrative
Visual and functional analysis was performed on the returned device.The reported deployment difficulty and resistance with the thumbslide was not confirmed.The reported stent elongation was unable to be confirmed as the stent was not returned.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other complaints reported from this lot.The investigation determined that the reported difficulties and subsequent patient effects were likely related to procedural circumstances.Based on the reported information, it is likely that the deployment difficulty and resistance with the thumbslide were the result of anatomical challenges.It is likely that the distal sheath of the delivery system was restricted or bent in the tight iliac bifurcation and heavily calcified lesion causing difficulty advancing the thumbslide resulting in deployment difficulty and stent elongation.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10621503
MDR Text Key209632008
Report Number2024168-2020-08228
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211843
UDI-Public08717648211843
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2022
Device Model NumberS-60-150-120-P6
Device Catalogue NumberS-60-150-120-P6
Device Lot Number0050661
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/28/2020
Date Manufacturer Received10/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SUPERA STENT; SUPERA STENT
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-